Nome Químico: N-((Z)-N'-(((2S,4S,5S)-4,5-Dihydroxytetrahydro-2H-pyran-2-yl)carbamoyl)carbamimidoyl)formamide
Sorrisos: O[C@@H]1[C@@H](O)CO[C@H](NC(/N=C(N)\NC([H])=O)=O)C1
Inchi: InChI=1S/C8H14N4O5/c9-7(10-3-13)12-8(16)11-6-1-4(14)5(15)2-17-6/h3-6,14-15H,1-2H2,(H4,9,10,11,12,13,16)/t4-,5+,6+/m0/s1
Development, validation, and clinical application of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantifica0074ion of total intracellular -decitabine nucleotides and genomic DNA incorporated -decitabine and 5-methyl-2 -deoxycytidine
Jeroen Roosendaal , Hilde Rosinga, Luc Lucas a, Aram Oganesianc, Jan H.M. Schellens b,d,e, Jos H. Beijnen
Journal of Pharmaceutical and Biomedical Analysis 164 (2019) 16–26
Isolation, characterization, and properties of a labile hydrolysis product of the antitumor nucleoside, 5-azacytidine
John A. Beisler
J. Med. Chem. 1978, 21, 2, 204–208
Stability indicating RP-HPLC Method Devlopment and Validation of Decitabine Drug in Formulation
Glory hepsiba1 *, Dr.B.B.Teja2 , K.Ashok kumar1 , Y.Ravindra reddy
International Journal of PharmTech Research CODEN (USA): IJPRIF Vol. 3, No.1, pp 237-243,
